F41, a Novel Fungal Indole-Diterpenoid, Overcomes Gemcitabine Resistance in Pancreatic Cancer by Inducing ER Stress
International Journal of Molecular Sciences · 03.11.2025 · 26 (21) · 10694
DOI: 10.3390/ijms262110694 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.11.2025. Verfasst von Zixiang Gao und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Respiratory Health and Multimorbidity, Key Laboratory of Antibiotic Bioengineering, Ministry of Health, Laboratory of Oncolog…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Deoxycytidine, Endoplasmic Reticulum Stress, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2023-I2M-2-001, 2021-1-I2M-030), Beijing Natural Science Foundation (7254505).
Abstract (Originalsprache)
Pancreatic cancer is an aggressive malignancy with a poor prognosis. It is characterized by low surgical resection rates, frequent development of chemoresistance, unsatisfactory treatment outcomes, and a high potential for recurrence and metastasis. Compound F41, a naturally occurring indole-diterpenoid secondary metabolite, was isolated from the entomopathogenic fungus Penicillium sp. Its anti-pancreatic cancer activity has not been previously reported. Our study demonstrates that F41 significantly inhibits DNA replication, invasion, and proliferation in pancreatic cancer cells. By elevating intracellular reactive oxygen species (ROS) levels in pancreatic cancer cells, F41 induces endoplasmic reticulum stress, ultimately leading to apoptosis. These findings suggest that F41 could effectively overcome gemcitabine resistance in a clinical setting, indicating its promise as a potential therapeutic agent for pancreatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Respiratory Health and Multimorbidity, Key Laboratory of Antibiotic Bioengineering, Ministry of Health, Laboratory of Oncology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sc…
- Institute of Medicinal Biotechnology Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100050, China.
ORCID-Profile: Yongsheng Che
Förderung
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2023-I2M-2-001, 2021-1-I2M-030)
- Beijing Natural Science Foundation (7254505)
Zitieren
APA
Gao, Z., Liu, L., Xu, Y., Zhao, C., Zhao, X., Zhao, T., Che, Y., & Zhao, W. (2025). F41, a Novel Fungal Indole-Diterpenoid, Overcomes Gemcitabine Resistance in Pancreatic Cancer by Inducing ER Stress. International Journal of Molecular Sciences, 26(21), 10694. https://doi.org/10.3390/ijms262110694
Vancouver
Gao Z, Liu L, Xu Y, Zhao C, Zhao X, Zhao T, et al. F41, a Novel Fungal Indole-Diterpenoid, Overcomes Gemcitabine Resistance in Pancreatic Cancer by Inducing ER Stress. International Journal of Molecular Sciences. 2025;26(21):10694. doi:10.3390/ijms262110694
BibTeX
@article{Gao2025,
author = {Gao, Zixiang and Liu, Li and Xu, Yang and Zhao, Cong and Zhao, Xiaojun and Zhao, Ting and Che, Yongsheng and Zhao, Wuli},
title = {F41, a Novel Fungal Indole-Diterpenoid, Overcomes Gemcitabine Resistance in Pancreatic Cancer by Inducing ER Stress},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {21},
pages = {10694},
doi = {10.3390/ijms262110694}
}
EUVIMED